Education
About Us
Working with TipRanks
Follow Us
Bioline RX Ltd Sponsored ADR (BLRX)
NASDAQ:BLRX
Total Valuation
Bioline RX Ltd Sponsored ADR has a market cap or net worth of $12.66M. The enterprise value is $16.15M.
Market Cap$12.66M
Enterprise Value$16.15M
Share Statistics
Bioline RX Ltd Sponsored ADR has 4,351,358 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,351,358
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bioline RX Ltd Sponsored ADR’s return on equity (ROE) is -0.69 and return on invested capital (ROIC) is -71.60%.
Return on Equity (ROE)-0.69
Return on Assets (ROA)-0.24
Return on Invested Capital (ROIC)-71.60%
Return on Capital Employed (ROCE)-0.87
Revenue Per Employee1.03M
Profits Per Employee-329.32K
Employee Count28
Asset Turnover0.74
Inventory Turnover2.95
Valuation Ratios
The current PE Ratio of Bioline RX Ltd Sponsored ADR is ―. Bioline RX Ltd Sponsored ADR’s PEG ratio is 0.84.
PE Ratio―
PS Ratio23.63
PB Ratio50.79
Price to Fair Value50.79
Price to FCF-15.56
Price to Operating Cash Flow-0.85
PEG Ratio0.84
Income Statement
In the last 12 months, Bioline RX Ltd Sponsored ADR had revenue of 28.94M and earned -9.22M in profits. Earnings per share was -0.12.
Revenue28.94M
Gross Profit19.68M
Operating Income-20.41M
Pretax Income-9.22M
Net Income-9.22M
EBITDA3.92M
Earnings Per Share (EPS)-0.12
Cash Flow
In the last 12 months, operating cash flow was -13.48M and capital expenditures 6.00K, giving a free cash flow of -13.48M billion.
Operating Cash Flow-13.48M
Free Cash Flow-13.48M
Free Cash Flow per Share-3.10
Dividends & Yields
Bioline RX Ltd Sponsored ADR pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.36
52-Week Price Change-16.67%
50-Day Moving Average2.91
200-Day Moving Average3.66
Relative Strength Index (RSI)35.55
Average Volume (3m)23.61K
Important Dates
Bioline RX Ltd Sponsored ADR upcoming earnings date is Mar 12, 2026, Before Open (Confirmed).
Last Earnings DateNov 24, 2025
Next Earnings DateMar 12, 2026
Ex-Dividend Date―
Financial Position
Bioline RX Ltd Sponsored ADR as a current ratio of 1.76, with Debt / Equity ratio of 58.25%
Current Ratio1.76
Quick Ratio1.56
Debt to Market Cap0.02
Net Debt to EBITDA1.18
Interest Coverage Ratio-2.23
Taxes
In the past 12 months, Bioline RX Ltd Sponsored ADR has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Bioline RX Ltd Sponsored ADR EV to EBITDA ratio is 175.68, with an EV/FCF ratio of -15.67.
EV to Sales23.78
EV to EBITDA175.68
EV to Free Cash Flow-15.67
EV to Operating Cash Flow-15.69
Balance Sheet
Bioline RX Ltd Sponsored ADR has $25.21M in cash and marketable securities with $11.38M in debt, giving a net cash position of $13.83M billion.
Cash & Marketable Securities$25.21M
Total Debt$11.38M
Net Cash$13.83M
Net Cash Per Share$3.18
Tangible Book Value Per Share$0.04
Margins
Gross margin is 50.69%, with operating margin of -70.52%, and net profit margin of -31.86%.
Gross Margin50.69%
Operating Margin-70.52%
Pretax Margin-31.86%
Net Profit Margin-31.86%
EBITDA Margin13.54%
EBIT Margin-0.51%
Analyst Forecast
The average price target for Bioline RX Ltd Sponsored ADR is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-41.76%
EPS Growth Forecast87.36%